# Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

> **NCT01290328** · NA · TERMINATED · sponsor: **Mehrotra, Anita, M.D.** · enrollment: 100 (estimated)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Epoetin Alfa

## Key facts

- **NCT ID:** NCT01290328
- **Lead sponsor:** Mehrotra, Anita, M.D.
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2014-03
- **Final completion:** 2014-04
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** low enrollment, termination of funding
- **Last updated:** 2014-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290328, "Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01290328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*